Log in to save to my catalogue

Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and...

Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_916520920

Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?

About this item

Full title

Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?

Publisher

Japan

Journal title

Annals of nuclear medicine, 2012-01, Vol.26 (1), p.77-85

Language

English

Formats

Publication information

Publisher

Japan

More information

Scope and Contents

Contents

Exact localization of recurrent iodine-negative thyroid cancer is mandatory, since surgery is the only curative therapy option in patients with iodine-negative tumor tissue. The aim of this study was to evaluate the impact of (18)F-FDG-PET/CT as a routine diagnostic tool on clinical management in patients with suspected thyroid cancer recurrence an...

Alternative Titles

Full title

Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_916520920

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_916520920

Other Identifiers

E-ISSN

1864-6433

DOI

10.1007/s12149-011-0545-4

How to access this item